2008: Treatment and Evaluation of Fibromyalgia
Search or Browse by Day

Treatment and Evaluation of Fibromyalgia

Sunday, October 26, 2008
720
FMRI Evidence For Modulation of Pain by Milnacipran in Fibromyalgia
721
An 8-week, Randomized, Double-blind, Placebo-controlled, Multi-center Study Of Esreboxetine Administered Once Daily In Patients With Fibromyalgia
722
Development of the Mental Clutter Scale
723
The Inability of Most US Patients to Tolerate the Recommended Doses of Pregabalin in the Treatment of FM
724
Low Levels of Vitamin D in Subjects With Chronic Widespread Pain are Explained by Lifestyle and Psychological Factors: Results From the European Male Ageing Study (EMAS)
725
Societal Costs and Disability Impact in Rheumatic Diseases
See more of: ACR Abstract Submission ACR Concurrent Abstract Session
<< Previous Session Level | Next Session Level >>